Journal article
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
Lancet neurology, v 16(2), pp 135-143
01 Feb 2017
PMID: 28102150
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Background
Despite progress in understanding the genetics of rare epilepsies, the more common epilepsies have proven less amenable to traditional gene-discovery analyses. We aimed to assess the contribution of ultra-rare genetic variation to common epilepsies.
Methods
We did a case-control sequencing study with exome sequence data from unrelated individuals clinically evaluated for one of the two most common epilepsy syndromes: familial genetic generalised epilepsy, or familial or sporadic non-acquired focal epilepsy. Individuals of any age were recruited between Nov 26, 2007, and Aug 2, 2013, through the multicentre Epilepsy Phenome/Genome Project and Epi4K collaborations, and samples were sequenced at the Institute for Genomic Medicine (New York, USA) between Feb 6, 2013, and Aug 18, 2015. To identify epilepsy risk signals, we tested all protein-coding genes for an excess of ultra-rare genetic variation among the cases, compared with control samples with no known epilepsy or epilepsy comorbidity sequenced through unrelated studies.
Findings
We separately compared the sequence data from 640 individuals with familial genetic generalised epilepsy and 525 individuals with familial non-acquired focal epilepsy to the same group of 3877 controls, and found significantly higher rates of ultra-rare deleterious variation in genes established as causative for dominant epilepsy disorders (familial genetic generalised epilepsy: odd ratio [OR] 2.3, 95% CI 1.7-3.2, p=9.1 x 10(-8); familial non acquired focal epilepsy 3.6, 2.7-4.9, p=1.1 x 10(17)). Comparison of an additional cohort of 662 individuals with sporadic non-acquired focal epilepsy to controls did not identify study-wide significant signals. For the individuals with familial non-acquired focal epilepsy, we found that five known epilepsy genes ranked as the top five genes enriched for ultra-rare deleterious variation. After accounting for the control carrier rate, we estimate that these five genes contribute to the risk of epilepsy in approximately 8% of individuals with familial non-acquired focal epilepsy. Our analyses showed that no individual gene was significantly associated with familial genetic generalised epilepsy; however, known epilepsy genes had lower p values relative to the rest of the protein-coding genes (p=5.8 x 10(-8)) that were lower than expected from a random sampling of genes.
Interpretation
We identified excess ultra-rare variation in known epilepsy genes, which establishes a clear connection I between the genetics of common and rare, severe epilepsies, and shows that the variants responsible for epilepsy risk are exceptionally rare in the general population. Our results suggest that the emerging paradigm of targeting of treatments to the genetic cause in rare devastating epilepsies might also extend to a proportion of common epilepsies. These findings might allow clinicians to broadly explain the cause of these syndromes to patients, and lay the foundation for possible precision treatments in the future.
Metrics
Details
- Title
- Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
- Creators
- Andrew S. Allen - Duke UniversitySusannah T. BellowsSamuel F. BerkovicJoshua Bridgers - Columbia UniversityRosemary BurgessGianpiero CavalleriSeo-Kyung ChungPatrick Cossette - Université de MontréalNorman Delanty - Royal College of Surgeons in IrelandDennis Dlugos - College Station Medical CenterMichael P. EpsteinCatharine FreyerDavid B. Goldstein - Columbia UniversityErin L. Heinzen - Duke UniversityMichael S. HildebrandMichael R. JohnsonDaniel H. LowensteinAnthony G. Marson - University of LiverpoolRichard Mayeux - Columbia UniversityCaroline MebaneHeather C. Mefford - St. Jude Children's Research HospitalTerence J. O'Brien - College Station Medical CenterRuth Ottman - Columbia UniversitySteven Petrou - College Station Medical CenterSlave Petrovski - The University of MelbourneWilliam O. PickrellAnnapurna Poduri - Boston Children's HospitalRodney A. RadtkeMark I. ReesBrigid M. Regan - The University of MelbourneZhong Ren - Columbia UniversityIngrid E. Scheffer - The University of MelbourneGraeme J. SillsRhys H. ThomasQuanli Wang - Columbia UniversityBassel Abou-Khalil - Vanderbilt UniversityBrian K. Alldredge - College Station Medical CenterDina AmromEva Andermann - McGill UniversityFrederick Andermann - McGill UniversityJocelyn F. Bautista - College Station Medical CenterSamuel F. BerkovicJudith Bluvstein - College Station Medical CenterAlex Boro - Montefiore Medical CenterGregory D. CascinoDamian ConsalvoPatricia Crumrine - University of PittsburghOrrin Devinsky - College Station Medical CenterDennis DlugosMichael P. Epstein - Emory UniversityMiguel Fiol - University of MinnesotaNathan B. Fountain - University of VirginiaJacqueline French - College Station Medical CenterDaniel Friedman - College Station Medical CenterEric B. GellerTracy GlauserSimon Glynn - College Station Medical CenterKevin Haas - Vanderbilt UniversitySheryl R. Haut - The Bronx DefendersJean Hayward - Drexel University, Medicine (Graduate)Sandra L. Helmers - Emory UniversitySucheta Joshi - University of MichiganAndres Kanner - Rush UniversityHeidi E. Kirsch - University of California, San FranciscoRobert C. Knowlton - University of Alabama at BirminghamEric H. Kossoff - Johns Hopkins HospitalRachel KupermanRuben Kuzniecky - College Station Medical CenterDaniel H. Lowenstein - University of California, San FranciscoPaul V. MotikaEdward J. Novotny - University of WashingtonJuliann M. Paolicchi - Vanderbilt UniversityJack M. Parent - College Station Medical CenterKristen Park - College Station Medical CenterAnnapurna Poduri - Boston Children's HospitalLynette G. Sadleir - University of OtagoIngrid E. SchefferRenee A. Shellhaas - University of MichiganElliott H. Sherr - University of California, San FranciscoJerry J. Shih - College Station Medical CenterShlomo Shinnar - The Bronx DefendersRani K. Singh - Wake Forest UniversityJoseph SirvenMichael C. Smith - Vanderbilt University Medical CenterJoseph Sullivan - University of California, San FranciscoLiu Lin Thio - College Station Medical CenterAnu Venkat - College Station Medical CenterEileen P. G. Vining - Johns Hopkins UniversityGretchen K. Von Allmen - College Station Medical CenterJudith L. Weisenberg - College Station Medical CenterPeter Widdess-WalshMelodie R. WinawerEpilepsy Phenome-Genome Proj
- Publication Details
- Lancet neurology, v 16(2), pp 135-143
- Publisher
- Elsevier
- Number of pages
- 9
- Grant note
- Epilepsy Research UK National Institute of Neurological Disorders and Stroke (NINDS); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS) U01NS077303 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS) G0800637 / Medical Research Council; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); European Commission G0800637 / MRC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:000391910800012
- Scopus ID
- 2-s2.0-85009876921
- Other Identifier
- 991021838152004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Clinical Neurology